US Vice President JD Vance has chosen not to endorse Israeli Prime Minister Benjamin Netanyahu in the upcoming election, diverging from President Donald Trump's public backing of Netanyahu. Vance emphasized his focus on endorsing American candidates for the midterms and stated he is neither for nor against Netanyahu. This stance comes amid a decline in US public support for Israel following the 2023 Hamas attack and ongoing debates about Netanyahu's government's response. Vance has previously engaged in foreign political endorsements but is refraining from involvement in Israeli politics this time.
US Vice President JD Vance's stance on Israeli leader Netanyahu is presented here with Pluang's market context for US stocks. For readers following US equities, as of Oct 20, 2026 08:31 WIB, out of 150 priced US stocks tradable on Pluang, 65 rose and 84 fell. Notable movers include PLTR at USD 194.38 with a 1-day change of +4.49% and a Pluang order activity of 46% Sell / 54% Buy, NVAX at USD 10.78 down 4.26% with 36% Sell / 64% Buy, and DKNG at USD 19.69 up 4.18% with 90% Sell / 10% Buy.
Anteris Technologies received regulatory approval from Germany's BfArM to start enrolling patients in its global PARADIGM trial for the DurAVR Transcatheter Heart Valve. This approval allows the company to recruit patients at leading German centers, ...
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Recce Pharmaceuticals has reached a key milestone in its Phase 3 trial for treating diabetic foot infections with its RECCE® 327 Gel (R327G). An independent Data Monitoring Committee will review unblinded data from 75 patients, following encouraging ...
Flipkart, owned by Walmart, is launching a food delivery service in India to compete against dominant players Zomato and Swiggy. The company is currently testing the service internally in Bengaluru with plans for a public launch by October and expans...
